Go
All Publishers
24-7 Press Release Newswire
3BL Media
AccessWire
Brandpoint
Chainwire
Evertise Digital
EZ Newswire
GlobeNewswire
Get Featured
IBN.ai
iCrowdNewswire
KeyCrew
Prodigy Press Wire
KoreWire
Law Firm Newswire
Media OutReach
MoneyShow Newswire
NewsDirect
NewsUSA
Newsworthy.ai
Pinion Newswire
Press Advantage
PR.com
PR Newswire
PRUnderground
FirstPublisher
Digital Press
RestaurantNews.com
Send2Press
Syndication Cloud
Press Services
Shan News Network
StatePoint Media
WebWire
T&T brand Organic Roasted Black Soybeans recalled due to undeclared milk
PR Newswire
Today at 4:25pm UTC
Amplifon Data Breach Investigation: Edelson Lechtzin LLP Probes Class Action Claims After Social Security Numbers and Health Records Are...
PR Newswire
Today at 4:16pm UTC
Minister Robertson highlights Budget 2026's plan to end homelessness within 10 years
PR Newswire
Today at 4:15pm UTC
Six AGIBOT G2 Robots Complete 1,730 Tasks in 24-Hour Shanghai Convenience Store Trial
GlobeNewswire
Today at 4:00pm UTC
Johnson & Johnson reports 73% PSA response rate with investigational pasritamig-based immunotherapy combination in advanced prostate...
PR Newswire
Today at 4:00pm UTC
SHAREHOLDER ALERT: Bronstein Gewirtz & Grossman, LLC Announces Class Action Against Tenax Therapeutics, Inc. (NASDAQ: TENX) — Investors...
GlobeNewswire
Today at 4:00pm UTC
Gildan Activewear Inc. (GIL) Investor Alert: GIL Stock Drops Further Amid Poor Q3 Earnings; December 14, 2026 Deadline - Contact Kessler...
GlobeNewswire
Today at 3:33pm UTC
LifeBiotic Launches Randomized Phase 2 Trial of Botanical Drug Candidate for Bladder Cancer Recurrence Prevention
PR Newswire
Today at 3:31pm UTC
Velinotamig, a BCMAxCD3 T Cell Engager, Achieves Complete Renal Responses and Significantly Reduces Disease Activity in Systemic Lupus...
GlobeNewswire
Today at 3:30pm UTC
GIL INVESTOR NOTICE: Gildan Activewear Inc. Investors with Substantial Losses May Seek to Lead Class Action Lawsuit Before December 14, 2026...
PR Newswire
Today at 3:30pm UTC
CRISPR Therapeutics Provides Update on Zugocabtagene Geleucel (Zugo-cel) in Refractory Rheumatologic Autoimmune Diseases
GlobeNewswire
Today at 3:30pm UTC
BETR DEADLINE ALERT: ROSEN, NATIONAL TRIAL COUNSEL, Encourages Better Home & Finance Holding Company Investors to Secure Counsel Before...
GlobeNewswire
Today at 3:25pm UTC
Statement by Minister Miller on Diwali
PR Newswire
Today at 3:00pm UTC
SHAREHOLDER ALERT: Bronstein Gewirtz & Grossman, LLC Announces Class Action Against D-Wave Quantum Inc. (NASDAQ: QBTS) — Investors Who...
GlobeNewswire
Today at 3:00pm UTC
Statement by Minister Miller on Bandi Chhor Divas
PR Newswire
Today at 3:00pm UTC
Cabaletta Bio Presents New Rese-cel Phase 1/2 Clinical Data at ACR Convergence 2026 Featuring Immunomodulator-Free Durability and Favorable...
GlobeNewswire
Today at 3:00pm UTC
Colin Kaepernick honored as Humanitarian of the Year at 2026 Muhammad Ali Humanitarian Awards
GlobeNewswire
Today at 3:00pm UTC
Statement by Prime Minister Carney on Bandi Chhor Divas
PR Newswire
Today at 2:30pm UTC
D-Wave Quantum Inc. (QBTS) Investors: December 15, 2026, Deadline in Securities Fraud Class Action Lawsuit - Kessler Topaz Meltzer &...
PR Newswire
Today at 2:27pm UTC
Hollywood & Sports Royalty Show Up for the Global Down Syndrome Foundation Fashion Show
GlobeNewswire
Today at 2:17pm UTC
<
1
2
3
4
5
6
...
19
20
>
Home
Weather
Services
About Us
Contact Us
Newsletters
eEdition
Special Sections
News
Local News
Government
Education
Public Safety
Sports
High School
College
Professional
Business
Lifestyle
Features
Announcements
Wheels
Events
Obituaries
Submit An Obituary
Opinion
Editorials
Letters To The Editor
Columnists
Submit An Opinion
Public Notices
Bid Notices
Classifieds
Public Notices
Place An Ad
Bid Notices
Subscribe
News
Sports
Business
Lifestyle
Events
Obituaries
Submit An Obituary
Opinion
Submit An Opinion
Newsletters
Public Notices
Bid Notices
Classifieds
Public Notices
Bid Notices
Place An Ad
eEdition
Special Sections